Skip to main content
    N

    NRX Pharmaceuticals Inc (NRXP)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.45
    +0.30 (+13.95%)

    Market Cap: $95.58M

    Last updated: Nov 17, 2026 at 4:40 PM ET

    NRX Pharmaceuticals Inc (NRXP) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    NRX Pharmaceuticals (NRXP) has a market cap of $95.58M. Its share count is up 94.19% from a year earlier.

    Total Valuation

    Market Cap$95.58M
    Latest price (Nov 17, 2026)$2.45

    Key Dates

    The next earnings report is expected on Mar 22, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 22, 2027 (expected)
    Last Earnings DateNov 16, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 14.67% in the quarter ended Sep 30, 2026 and grew 98.34% a year over 2 years.

    Shares Outstanding43.17M
    Shares Change (YoY)+94.19%
    Shares Change (QoQ)+14.67%
    Share Count Growth (2Y CAGR)+98.34%

    Valuation Ratios

    The price to sales ratio is 24.5x.

    P/S Ratio24.5x
    Forward P/S17.0x

    Price Statistics

    The stock is down 1.61% over 52 weeks and trades 11.55% below its 50-day average.

    Beta (1Y)2.16
    52-Week Change-1.61%
    1-Month Change-6.84%
    3-Month Change-26.43%
    6-Month Change-19.14%
    5-Year Change-97.76%
    Total Return (1Y)-1.61%
    Total Return (3Y CAGR)-7.47%
    Total Return (5Y CAGR)-45.32%
    Return vs SPY (1Y)-4.10%
    Max Drawdown (1Y)-53.46%
    Max Drawdown (3Y)-83.44%
    Sharpe Ratio (1Y)0.09
    Correlation with SPY (1Y)0.36
    50-Day Average$2.77
    200-Day Average$2.98
    52-Week Range$1.62 to $5.05
    RSI (14 Days)48.3
    Average Volume (20 Days)1.75M

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 0.76x current liabilities.

    Current Ratio0.76x
    Quick Ratio0.76x
    Interest Coverage-17.78x

    Returns and Efficiency

    Return on Assets (ROA)-71.06%
    Receivables Turnover20.33x

    Scores

    NRXP has an Altman Z-Score of -17.40, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Altman Z-Score-17.40
    Altman Z ZoneDistress
    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Stock Splits

    The last split was a 1-for-10 reverse split on Apr 2, 2024.

    Last Split DateApr 2, 2024
    Split TypeReverse split
    Split Ratio1:10

    Analyst Forecast

    Consensus estimates put revenue growth at 695.35% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+695.35%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About NRXP

    What is NRXP's market cap?

    NRX Pharmaceuticals has a market cap of $95.58M.

    How many shares of NRXP are outstanding?

    NRX Pharmaceuticals has 43.17M shares outstanding. The count is up 94.19% from a year earlier.

    Does NRXP pay a dividend?

    No. NRX Pharmaceuticals does not pay a dividend.